Start Date
December 31, 2008
Primary Completion Date
April 30, 2009
Study Completion Date
April 30, 2009
Efalizumab
1 mg/kg of efalizumab administered sub q once weekly
University of California, San Francisco, San Francisco
Collaborators (1)
Genentech, Inc.
INDUSTRY
University of California, San Francisco
OTHER